Skip to main content

MARIMED INC.

corporate_fare Company Profile

MARIMED INC.

MRMD·OTC·Life Sciences·CIK 0001522767

We are a multi-state cannabis operator (MSO) in the United States, headquartered in Norwood, Massachusetts. We develop, own, and manage state-licensed, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis, operating on a seed-to-sale model. We create and develop our own brands of premium cannabis flower, concentrates, edibles, and other precision-dosed products using our proprietary strains and formulations. We also license our proprietary brands in select domestic markets, though these revenues are not material to our overall results. Our operations comply with applicable state and local laws and regulations in the jurisdictions where we operate, as cannabis remains illegal under United States federal law. We entered the cannabis industry as an advisory and real estate management firm, procuring state-issued cannabis licenses for clients, developing facilities leased to them, and providing expertise. In 2018, we transitioned to a direct owner and operator of cannabis licenses, primarily in Eastern and Midwestern states. This involved acquiring and consolidating clients for whom we had secured licenses, developed facilities, funded operations, and provided guidance. By early 2025, we had substantially completed these acquisitions and integrations. Our operations expanded through additional M&A activity, making us one of the larger MSOs in the U.S. based on reported annual revenue. We have consistently created our own brands of craft-quality cannabis flower, concentrates, edibles, and other precision-dosed products.

MARIMED INC. (OTC:MRMD) is a publicly traded company in the Life Sciences sector. Wiseek monitors MRMD SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Q1 Results Show Improved Profitability; DOJ Cannabis Rescheduling Offers Major Tax Relief
  • MariMed Reports Improved Q1 Profitability with 44% Adjusted EBITDA Growth
  • MariMed Reports Q1 Net Loss of $3.8M on $39.5M Revenue, Adjusted EBITDA at $3.6M
  • MariMed Proxy Details Extensive Related-Party Transactions and CEO Guarantees Amidst Financial Distress
  • MariMed Reports Increased Net Loss, $7.3M in IRS Tax Liens, and Debt Restructuring in 2025 Annual Report

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$159.83M
Net Income
-$14.48M
Diluted EPS
-$0.04
Op. Cash Flow
$7.7M
Free Cash Flow
$6.53M
Gross Profit
$57.88M
Operating Income
-$2.82M
Cash & Equivalents
$8.88M
Total Debt
$76.04M
Debt / Equity
1.52×
Net Margin
-9.1%
Shares Outstanding
396.91M sh
Source: 10-K · filed 2026-03-12 · accession 0001522767-26-000030
Browse all tickers starting with M →
$0.069
52-week range · as of 2026-05-14 $0.0641 – $0.23
Market cap
$27.55M
Volume
921.5K (1.4× avg)
3-mo avg 656.5K
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MRMD - Latest Insights

MRMD
May 14, 2026, 4:19 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0815
Real-time Price: $0.069 info
Change: -$0.0125 (-15%) info
Market Cap: $27.549M info
MRMD
May 13, 2026, 5:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.084
Real-time Price: $0.069 info
Change: -$0.015 (-18%) info
Market Cap: $27.549M info
MRMD
May 13, 2026, 5:00 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.084
Real-time Price: $0.069 info
Change: -$0.015 (-18%) info
Market Cap: $27.549M info
MRMD
Apr 23, 2026, 4:06 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.079
Real-time Price: $0.069 info
Change: -$0.0100 (-13%) info
Market Cap: $27.549M info
MRMD
Mar 12, 2026, 4:08 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $0.07714
Real-time Price: $0.069 info
Change: -$0.00814 (-11%) info
Market Cap: $27.549M info
MRMD
Mar 11, 2026, 5:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.07945
Real-time Price: $0.069 info
Change: -$0.01045 (-13%) info
Market Cap: $27.549M info
MRMD
Mar 02, 2026, 4:15 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.081
Real-time Price: $0.069 info
Change: -$0.012 (-15%) info
Market Cap: $27.549M info
MRMD
Mar 02, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.081
Real-time Price: $0.069 info
Change: -$0.012 (-15%) info
Market Cap: $27.549M info